Financial News · Live Terminal

Page 9 of 4249

Quantum Cyber Seeks Partners to Build Prototype of New Quantum-Based Drone Antenna

Quantum Cyber (QUCY) is seeking manufacturing partners, foundries and applied research organizations to help build the first working prototype of its exclusively licensed quantum-photonic antenna front-end for drone communications in contested environments.The system is designed to support resilient, frequency-agile communications, with applications due Sept. 18 before selected respondents enter confidential technical discussions ahead of any prototype-development or manufacturing agreement, the company said Friday in a statement.Price: $1.56, Change: $+0.04, Percent Change: +2.63%

$QUCY

Commodities1d ago

US Gasoline Prices Rise on Higher Crude, Refining Margins, EIA Says

Higher crude prices and elevated refining margins are pushing US gasoline costs higher, with regional prices reaching $5.21 per gallon on the West Coast, the US Energy Information Administration said Friday.Gasoline crack spreads in New York Harbor have averaged about $1/gal above 2025 levels since May, when the measure peaked at about $0.60/gal.Global refining disruptions in Russia, China and the Middle East have tightened gasoline supplies, raising import costs and increasing demand for US gasoline exports, the EIA said.Since March, US gasoline imports, including finished fuel and blending components, have averaged 32% below the 2021-2025 five-year average, while Gulf Coast shipments have partly offset the decline.Distillate and jet fuel crack spreads have risen further as overseas refineries, which normally produce larger volumes of those fuels, have been disrupted, prompting US refiners to shift output toward them.Since March, the New York Harbor distillate fuel oil crack spread has averaged 74 cents/gal above the gasoline crack spread.For the week ended Aug. 28, US distillate inventories stood 14% below the five-year average, while gasoline inventories remained 6% below average, the EIA said.On the Monday before Labor Day, US gasoline prices averaged $4.07/gal, with the Midwest at $3.85/gal, East Coast at $3.94/gal and Gulf Coast at $3.62/gal.West Coast gasoline averaged $5.21/gal, while Rocky Mountain prices reached $4.27/gal, reflecting regional differences in supply, demand and fuel taxes, according to EIA.

Commodities1d ago

Marauder Capital acquires Montco Power Solutions

Marauder Capital said on Friday it had acquired Montco Power Solutions, a Louisiana-based provider of mobile power equipment to companies across the US energy production value chain.Financial terms of the transaction were not disclosed.Montco operates facilities in Midland, Pecos and Pleasanton and provides mobile power services across Texas, Louisiana and New Mexico. The company serves major energy companies and provides mobile power equipment to support operations across the energy production value chain.Marauder said demand for mobile power in the markets served by Montco continues to increase, creating opportunities for the company to expand its capacity and customer offerings.

Wire1d ago

Take-Two Interactive Releases NBA 2K27 Globally

Take-Two Interactive Software (TTWO) said Friday it launched the video game title NBA 2K27 globally on Sony's (SONY) PlayStation 5, Microsoft's (MSFT) Xbox Series X/S, Nintendo's Switch, and PC.The game is available in standard, deluxe, and limited-time editions across multiple price tiers, along with updated gameplay mechanics, expanded career modes, and multiplayer options, the company said.The PC version comes with updated graphics and Nvidia's (NVDA) Deep Learning Super Sampling 5 technology, Take-Two Interactive said.Price: $213.95, Change: $-0.19, Percent Change: -0.09%

$MSFT$NVDA$SONY$TTWO

Mining & Metals1d ago

Reconnaissance Energy Africa Files Prospectus Supplement For CA$19 Million Upsized Public Offering

Reconnaissance Energy Africa (RECO.V) filed a prospectus supplement to the company's final short-form base shelf prospectus dated Apr. 13, with the securities commissions in each of the provinces and territories in Canada, it said in a statement on Friday.The filing of the prospectus supplement was made in connection with its upsized bought-deal public offering of units for CA$19 million.Shares of the company were last seen down about 3% at CA$0.65 on the TSX Venture Exchange.Price: $0.65, Change: $-0.02, Percent Change: -2.99%

$RECO.V

Wire1d ago

Climb Bio's Phase-1 Data From IgA Nephropathy Trial 'Positive,' Wedbush Says

Climb Bio's (CLYM) data from the first phase of its trial evaluating CLYM116 in patients with IgA nephropathy was "positive," Wedbush analysts said in a Friday note.Analysts said they see favorable risk/reward for Climb Bio's shares as additional phase 1 data will likely be presented at the American Society of Nephrology.Some investors were looking for a more clear-cut "winner" between Climb Bio and Jade Biosciences (JBIO) in their nephropathy clinical trials, Wedbush said.Analysts said they expect the valuation gap between Climb Bio and Jade Biosciences to narrow over time as both agents offer benefits compared with first-gen agents.Wedbush kept its outperform rating and a $25 price target on the stock.Shares of the company were up nearly 8% in Friday trading.Price: $15.75, Change: $+1.16, Percent Change: +7.95%

$CLYM$JBIO

Wire1d ago

Guidewire Software Delivers Strong Close to Fiscal 2026, Oppenheimer Says

Guidewire Software (GWRE) delivered a solid close to fiscal 2026, with its Q4 annual recurring revenue coming in above the high end of guidance, and forecast 18% growth excluding forex for fiscal 2027, Oppenheimer said in a note Friday.The investment firm said it was "comforted to see pipeline conversion return to normal, and incrementally positive on PricingCenter traction."Oppenheimer said it sees potential for estimates to trend higher as management is approaching the outlook prudently.The firm noted that the fiscal 2027 annual recurring revenue outlook at $1.45 billion to $1.46 billion bracketed consensus but was also likely a shade below bullish expectations of over 18%. Management's outlook assumes that fiscal 2027 attrition normalizes against record-low levels, and lower backlog mix, according to the note.Oppenheimer reiterated its outperform rating on Guidewire and lifted the price target to $210 from $200.Shares of Guidewire Software were down 22% in Friday trading.Price: $158.24, Change: $-44.62, Percent Change: -22.00%

$GWRE

Wire1d ago

Update: Concrete Pumping Shares Rise After Q3 Beat, Higher Full-Year Outlook

(Updates with the latest stock price movement in the headline and first paragraph, and dividend information in the last paragraph.)Concrete Pumping Holdings (BBCP) shares rose more than 19% in Friday trading, a day after the company reported a fiscal Q3 beat and raised its fiscal year outlook.The company reported fiscal Q3 earnings late Thursday of $0.09 per diluted share, up from $0.07 a year earlier.Two analysts polled by FactSet expected a loss of $0.08.Revenue for the three months ended July 31 was $116.8 million, up from $103.7 million a year earlier.Three analysts surveyed by FactSet expected $110.2 million.The company now expects fiscal 2026 revenue of between $425 million and $435 million, up from the previous guidance of $410.0 million to $425.0 million.Three analysts expect $421.1 million.The company announced its first quarterly cash dividend of $0.13 per share, payable Oct. 2 to stockholders of record as of Sept. 18.Price: $10.87, Change: $+1.82, Percent Change: +20.08%

$BBCP

Wire1d ago

Alnylam's Zilebesiran Sees Commercial Opportunity From Baxfendy Launch, Oppenheimer Says

Alnylam Pharmaceuticals' (ALNY) zilebesiran product candidate could see a "significant commercial opportunity" from the solid launch of rival hypertension treatment Baxfendy, Oppenheimer said in a Thursday note.AstraZeneca's (AZN) Baxfendy was approved in May and its sales jumped about 3,000% at week 12 after the approval, reaching about $1.6 million per week, the brokerage said.Oppenheimer said zilebesiran's potential cardiovascular benefit, effective blood-pressure reduction, infrequent dosing and favorable safety profile could support strong launch prospects and differentiate it from competing therapies.Zilebesiran's Q6M dosing could also improve treatment adherence and reduce treatment burden, particularly given that about 73% of patients in Baxfendy's phase 3 trial were taking three or more antihypertensive medications. The investment firm noted zilebesiran's lower rate of elevated potassium in Kardia-3 compared with Baxfendy.Oppenheimer has an outperform rating and a $350 price target on Alnylam Pharmaceuticals.Price: $264.61, Change: $+0.11, Percent Change: +0.04%

$ALNY

Treasury1d ago

Noba Bank Group Issues SEK350 Million Subordinated Tier 2 Notes

Noba Bank Group (NOBA.ST) issued 350 million kronor of subordinated tier 2 notes, with settlement due Sept. 11, according to a Friday release.The notes have a tenor of 10.4 years, with a first call date option after 5.1 years, and a coupon of three-month Stockholm Interbank Offered Rate plus 2.22%. The notes are slated for listing on Nasdaq Stockholm.Nordea and Danske Bank served as joint lead managers for the notes issue, which was carried out under the specialist bank's 10 billion-krona medium-term note program.

$NOBA.ST

Wire1d ago

Update: Morgan Stanley Raises Price Target on DocuSign to $75 From $69, Maintains Equalweight Rating

(Updated with Morgan Stanley's comments).Morgan Stanley raised its price target on DocuSign (DOCU) to $75 from $69 following its better-than-expected Q2 and modest guidance raise.While the results show incremental IAM progress, Morgan Stanley highlighted that management still hasn't quantified pricing uplift or incrementality vs. legacy eSignature migration.DocuSign has an average rating of hold and mean price target of $68.33, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $67.56, Change: $+1.59, Percent Change: +2.41%

$DOCU

Wire1d ago

Trulieve Cannabis Establishes Medical Marijuana Retail Location in Georgia

Trulieve Cannabis (TRLV) said Friday it has set up a new medical marijuana retail site in Dunwoody, Georgia.The dispensary will host an official launch event on Thursday and supply proprietary brand formulations alongside digital patient registration resources, the company said.

$TRLV

Wire1d ago

UiPath Posts Solid Fiscal Q2, Growth Re-acceleration Remains Limited, Oppenheimer Says

UiPath (PATH) delivered a solid fiscal Q2 but the results provided limited evidence of sustained growth re-acceleration, with the revenue beat driven mainly by professional services and licenses rather than subscriptions.Management highlighted improving annual recurring revenue growth, execution and cost discipline, while guiding for fiscal Q3 ARR of about $1.99 billion to $2.00 billion and revenue of $440 million to $445 million, with adjusted operating income expected at $100 million.Oppenheimer said the company also raised fiscal 2027 guidance, with ARR now expected at $2.065 billion to $2.07 billion; revenue at $1.789 billion to $1.794 billion, and adjusted operating income at $445 million.The analysts highlighted Q2 net new ARR growth of 19% to $37 million and 109% net retention, but noted that subscription revenue missed consensus and Q3 guidance implied a 4% year-over-year decline in net new ARR at the midpoint.Oppenheimer maintained its perform rating on the stock.Shares of UiPath fell more than 13% in recent Friday trading.Price: $15.72, Change: $-2.51, Percent Change: -13.75%

$PATH

Wire1d ago

Ionis Pharmaceuticals' Zanvastro Approval Sets Path for Independent Neurology Business, Oppenheimer Says

Ionis Pharmaceuticals (IONS) has established its first independently commercialized neurology asset with the approval of Zanvastro for Alexander disease, Oppenheimer said in a Friday note.The US Food and Drug Administration approval creates an infrastructure, a clinical network and a commercial foundation that can be leveraged for future central nervous system, or CNS, targeted drug launches, the firm said.Oppenheimer said the approval also provides further validation of the company's CNS antisense drug development capabilities, while noting it provides favorable read-through for obudanersen, whose phase 3 study recently completed enrollment.Oppenheimer maintained its outperform rating on Ionis Pharmaceuticals and $85 price target.Price: $58.28, Change: $+0.15, Percent Change: +0.26%

$IONS

Wire1d ago

Adlai Nortye's KRAS Opportunity Further Validated by GSK-Hutchmed Deal, Oppenheimer Says

Adlai Nortye (ANL) stands to benefit from the GSK (GSK)-Hutchmed (HCM) deal, which validates growing interest in targeted KRAS therapies, Oppenheimer said in a note emailed Friday.Hutchmed said Thursday its unit licensed rights to GSK to develop and commercialize experimental cancer treatment HMPL-A830 outside Greater China.HMPL-A830 is an EGFR-targeted antibody-drug conjugate carrying a KRAS inhibitor payload. The deal highlights increasing interest in targeted approaches that aim to improve the therapeutic index of RAS-pathway inhibition, Oppenheimer analysts said.Adlai Nortye's approach is differentiated, with AN9025 already in the clinic and data expected in H1 2027. AN4035 uses a pan-RAS(ON) inhibitor payload with a CEACAM5-targeting antibody, which could provide advantages in breadth, durability, and target selection, the analysts added.The deal should improve "investor awareness of comparable RAS-focused platforms and reinforce the strategic value embedded within Adlai Nortye's differentiated RAS franchise," the analysts said.Oppenheimer has an outperform rating and a $32 price target on Adlai Nortye.Price: $15.14, Change: $+0.39, Percent Change: +2.64%

$ANL

Wire1d ago

Shell, Equinor's Jackdaw Gas Field Reportedly Expected to Get UK Drilling Approval

Shell (SHEL) and Equinor's (EQNR) Jackdaw gas field in the North Sea is expected to receive UK government approval for new drilling this month, news outlets reported Friday.Approval for the project, off the coast of Aberdeen, may come as soon as mid-September, just before Parliament breaks for party conferences, the BBC reported, citing government and industry sources.Energy Secretary Miatta Fahnbulleh is expected to approve Jackdaw with a decision on Rosebank, a separate oilfield, anticipated later, the Financial Times reported, citing people familiar with the matter"We do not comment on speculation," a spokesperson from the government's Department for Energy Security and Net Zero said in an emailed statement to. "The North Sea remains a vital national asset and oil and gas will continue to play an important role in our energy system for decades to come, alongside transitioning to clean power to protect jobs and tackle the climate crisis.""Any decision will take into account all relevant evidence, including environmental assessments and public representations received during the consultation process," the statement said.Shell and Equinor didn't immediately respond to requests for comment.Shell shares rose 0.8% in Friday trading, and Equinor fell 0.8%.Price: $93.09, Change: $+0.76, Percent Change: +0.82%

$EQNR$SHEL

Treasury1d ago

Canada Lost 42,000 Jobs But Worked Longer Hours in August

Canada lost 42,000 jobs but the longer hours worked in August, raising implications for gross domestic product (GDP) tracking and interest rates.While the figures suggest employers are being more restrained in hiring new staff, hours worked were up by a seasonally-adjusted 0.6% month on month, and are tracking a third-quarter gain of about 5% quarter-on-quarter SAAR. This would be the biggest gain since the fourth quarter of 2021, wrote Scotiabank vice president of economics, Derek Holt."The implications for GDP and the Bank of Canada are mixed but more hawkish than dovish; they won't overreact to August jobs but GDP tracking may ring alarms," Holt added, noting that GDP is hours worked times labor productivity.However, CIBC executive director and senior economist Andrew Grantham said markets had been pricing in an earlier start to Bank of Canada hikes, but Friday's jobs data saw "these pushed back again and bond yields decline".The new US tariffs were implemented too late in August to significantly impact this morning's labor market data, but early signs including job openings from Indeed.com have not seen a significant pullback in hiring demand, wrote RBC senior economist Claire Fan.She continues to expect solid domestic demand that will support further labor market improvement into 2027.The 42,000 job print missed market expectations for a 15,000 gain, and offset more than half of the 75,000 increase recorded in July. By sector, business, building & support saw the largest drop in employment, shedding 20,000 jobs.

$CXY

Wire1d ago

Baidu Shares Included in Shanghai-Hong Kong Stock Connect Program

Baidu's (BIDU) class A ordinary shares traded on the Hong Kong Stock Exchange will be included in the Shanghai-Hong Kong Stock Connect program effective Sept. 7, the company said Friday.Eligible investors in mainland China will have direct access to the trading of Baidu's shares through the program, according to a statement.Price: $97.67, Change: $+2.09, Percent Change: +2.18%

$BIDU

Commodities1d ago

Australia's Oil Producers Look Overseas as Domestic Supply Declines, IEEFA Says

The start of production at Santos's 80,000-barrel-per-day Pikka oil project in Alaska highlights how Australia's biggest oil and gas companies are increasingly turning overseas as domestic oil supplies decline, Institute for Energy Economics and Financial Analysis analyst Kevin Morrison said in a Friday note.The shift comes as concerns over Australia's fuel security have grown, with the conflict in Iran putting greater focus on reliable fuel supplies.Australia imported about 95% of the fuel it consumed last financial year, when daily consumption averaged about 1.08 million barrels, according to government data. Domestic oil production has fallen to about 46,600 barrels per day, its lowest level since the late 1960s.Australia had 213.4 million barrels of proven and probable oil reserves at the end of 2024, down 6.8% from a year earlier, Morrison said, citing Geoscience Australia data. The reserves amount to slightly more than six months of current consumption.The country also has far larger reserves of condensate, a lighter petroleum product. But Australia's two refineries cannot process it, so most of the condensate is exported, mainly to Singapore. Including condensate in oil reserve figures can therefore overstate the country's usable crude oil supply.Limited prospects for major new oil discoveries have encouraged Santos and rival Woodside Energy to expand overseas.Santos is developing Pikka despite having discovered the Dorado oil and gas field off Western Australia in 2018. Dorado has 162 million barrels of oil and condensate resources, compared with 400 million barrels of proven and probable oil reserves at Pikka, plus another 600 million barrels of potentially recoverable resources.Woodside has similarly expanded its international portfolio, acquiring Gulf of Mexico assets through its 2022 merger with BHP's petroleum business. Its Sangomar field offshore Senegal, which began production in 2024, produced more than twice as much oil as its Australian operations in the first half of 2026.Woodside is also developing the 110,000-barrel-per-day Trion field offshore Mexico, due to start production in 2028.Although Australian oil exploration spending reached a 10-year high in early 2026, early results suggest several frontier areas may offer greater gas than oil potential.Analysts say increased drilling alone is unlikely to significantly improve Australia's fuel security. Reducing oil demand, particularly by shifting transport to electric vehicles, could have a greater impact on the country's reliance on imports.

Asia Markets1d ago

European Equities Traded in the US as American Depositary Receipts Marginally Higher in Friday Trading

European equities traded in the US as American depositary receipts were marginally higher late Friday morning, rising 0.08% to 1,976.36 on the S&P Europe Select ADR Index, which was up about 0.9% for the week so far.From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and 3D printer company Materialise (MTLS), which rose 2% and 1.6%, respectively. They were followed by biotech firm BioNTech (BNTX), which gained 0.8%.The decliners from continental Europe were led by accommodations booking site trivago (TRVG) and oil and gas company Eni (E), which dropped 3.1% and 2.2%, respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and biopharmaceutical company DBV Technologies (DBVT), which were down 2.1% and 1.7%, respectively.The gainers from the UK were led by telecommunications operator Vodafone Group (VOD) and oil and gas company Shell (SHEL), which advanced 2.2% and 0.9%, respectively. They were followed by oil and gas company BP (BP) and medical device maker Smith & Nephew (SNN), which were up 0.7% and 0.6%, respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and biotech firm Trinity Biotech (TRIB), which lost 4.5% and 3%, respectively. They were followed by software firm Endava (DAVA) and communications company WPP (WPP), which fell 2.6% and 2.2%, respectively.

$BNTX$BP$DBVT$E$EVAX$MREO$MTLS$NOK$NVO$SHEL$SNN$TRIB$TRVG$VOD

Showing 161-180 of 84976

Commodities1d ago